论文部分内容阅读
甲型肝炎灭活疫苗 (VAQTA)于 1996年就获准在美国用于预防甲型肝炎病毒(HAV)感染 ,常用程序是注射两针 ,健康儿童和青少年在 6～ 18个月时作第 2针加强 ,而 19岁以上成人在 6个月时加强。作者对成年人注射第 1针 VAQTA后 12或 18个月加强 1针与 6个月加强 1针的免疫应答是否相?
Hepatitis A Inactivated Vaccine (VAQTA) was approved in the United States in 1996 for the prevention of Hepatitis A virus (HAV) infection. The usual procedure is injection of two doses. Healthy children and adolescents receive the second dose at 6-18 months Strengthened while adults over the age of 19 strengthened at 6 months. Do the authors either 12-and 18-month-old after injecting the first injection of VAQTA in adults phase 1 and 6 months to strengthen the 1-pin immune response phase?